T Cell Immunoprofiling of Patients with Relapsed and/or Refractory Myeloma Who Receive Daratumumab Monotherapy: Longitudinal Analysis during 7 Cycle Follow-up of the Rebuild Phase 2 Study
T Cell Immunoprofiling of Patients with Relapsed and/or Refractory Myeloma Who Receive Daratumumab Monotherapy: Longitudinal Analysis during 7 Cycle Follow-up of the Rebuild Phase 2 Study
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2020
Συγγραφείς:
Vlachonikola, Elisavet Kastritis, Efstathios Hatjiharissi, Evdoxia Katodritou, Eirini Siorenta, Alexandra Sofou, Electra Gerousi, Marina Kotta, Konstantia Karipidou, Maria Gavriatopoulou, Maria others
